Texan Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Texan Capital Management's NVS Position: Q4 2017 in Review
Texan Capital Management reduced its Novartis (NVS) stake by 4.5% in Q4 2017, selling an estimated $139K and leaving 39,043 shares worth $2.94M. The position accounts for 1.91% of the portfolio, ranked #15.
Texan Capital Management first reported a position in NVS in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.15M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.
- Texan Capital Management held 39,043 shares of Novartis worth $2.94M as of Q4 2017.
- Texan Capital Management sold 1,842 Novartis shares in Q4 2017, an estimated $139K.
- Novartis made up 1.91% of Texan Capital Management's portfolio in Q4 2017, its #15 holding.
- Texan Capital Management first reported a position in Novartis in Q2 2013 and has held it in 19 quarters since.
- Texan Capital Management's Novartis position peaked at $3.15M in Q3 2017.
- 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.
Based on Texan Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.